PHASE I STUDY OF VINCRISTINE, DOXORUBICIN, AND DEXAMETHASONE (VXD) PLUS IXAZOMIB IN ADULTS WITH RELAPSED OR REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA, LYMPHOBLASTIC LYMPHOMA OR MIXED PHENOTYPE ACUTE LEUKEMIA: